questions
0

Facioscapulohumeral Muscular Dystrophy

Author:
Topic updated on 11/21/14 11:04am
Introduction
  • A neuromuscular disorder which causes progressive muscle weakness in the face (facio), shoulder girdle (scapulo), and upper arm (humeral)
  • Epidemiology
    • incidence
      • third most common muscular dystrophy after Duchenne and myotonic dystrophy
      • 1 in 14,000 births
    • demographics
      • male = female
      • males more severely affected
      • 95% present prior age of 20
  • Genetics
    • inheritance pattern
      • autosomal dominant
    • mutation
      • gene defect, FRG1, on chromosome 4q35 (160,161)
  • Associated Conditions
    • orthopaedic manifestations
      • scoliosis (rare)
  • Prognosis
    • insidious disease course; 20% of individuals eventually require a wheelchair
    • life expectancy is NOT shortened
Classification
  • Type 1A (FSHD1A)
    • most common form
    • also referred to as chromosome 4 linked
  • Type 1B (FSHD1B)
    • rare
    • also referred to as non-chromosome 4 linked
  • Infantile
    • more severe subtype of Type 1A and 1B and symptoms present earlier (~ 5 years old)
    • most patients become wheelchair bound during the 2nd decade of life
    • marked lumbar lordosis is progressive and is pathognomonic for infantile FSHD 
    • hearing loss, vision problems and seizures have been documented
    • have severely compromised pulmonary function and succumb in early adolescence
Presentation
  • Symptoms
    • slow muscular weakness over time
  • Physical Exam
    • inspection
      • scapular winging with limited arm abduction
        • causing prominent shoulder blades
      • incomplete eye closure
      • transverse smile
      • absence of eye and forehead wrinkles
      • selective sparing of deltoid, distal part of pectoralis major, and erector spinae muscles
    • motion
      • marked decrease in shoulder flexion and abduction
Studies
  • Labs
    • CPK levels usually normal
  • Electrodiagnostic
    • EMG usually shows mild myopathic changes
  • Muscle Biopsy
    • nonspecific chronic myopathic changes
    • performed only in those individuals in whom FSHD is suspected but not confirmed by molecular genetic testing
  • Genetic Testing
    • 95% sensitive and highly specific for FSHD
Treatment
  • Nonoperative
    • PT/OT, speech therapy
      • indications
        • shoulder girdle and upper arm weakness
          • to maintain strength and range of motion of affected muscles
      • outcomes
        • although their arms become gradually weaker from adolescence on, patients can usually work into later life
  • Operative
    • scapulothoracic fusion
      • indications
        • scapular winging
      • technique
        • wiring of the medial border of the scapula to ribs three through seven
        • internal fixation is achieved with 16-gauge wire
        • wires ensure firm fixation and eliminate the need for postoperative immobilization and subsequent rehabilitation
        • child uses a sling for 3 to 4 days postoperatively, and then begins a physical therapy program
      • outcomes
        • increased active abduction and forward flexion of the shoulder, and improved function as well as cosmesis

 

Please Rate Educational Value!
3.0
Average 3.0 of 4 Ratings

Qbank (0 Questions)





Topic Comments